Advertisement
U.S. markets closed

Exagen Inc. (XGN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
1.5900+0.0300 (+1.92%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close1.5600
Open1.5700
Bid1.5500 x 100
Ask1.6700 x 100
Day's Range1.5300 - 1.6487
52 Week Range1.3300 - 3.9230
Volume26,039
Avg. Volume43,172
Market Cap27.405M
Beta (5Y Monthly)1.23
PE Ratio (TTM)N/A
EPS (TTM)-1.3400
Earnings DateMay 13, 2024 - May 17, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for XGN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Exagen Inc.
    Daily – Vickers Top Buyers & Sellers for 03/06/2024The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    23 days agoArgus Research
View more